Constitutive association of MyD88 to IRAK in HTLV-I-transformed T cells

Experimental Hematology

Volumn 35, Issue 12, 2007, Pages 1812-1822

  Mizobe, Takamitsu ^a   Tsukada, Junichi ^b   Higashi, Takehiro ^a   Mouri, Fumihiko ^a   Matsuura, Ai ^a   Tanikawa, Rena ^a   Minami, Yasuhiro ^c   Yoshida, Yasuhiro ^a   Tanaka, Yoshiya ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b School of Medicine   (Japan)

^c KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; MESSENGER RNA; MYELOID DIFFERENTIATION FACTOR 88; NUCLEAR FACTOR; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 10; TOLL LIKE RECEPTOR 6; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSFORMATION; CONTROLLED STUDY; EXPRESSION VECTOR; GENE EXPRESSION REGULATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; VIRUS TRANSFORMATION;

BASE SEQUENCE; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, VIRAL; DNA PRIMERS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN BINDING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES;

HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 36249023246     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2007.08.008     Document Type: Article

References (58)

1. Sagawa K., Mochizuki M., Masuoka K., et al. Immunopathological mechanisms of human T cell lymphotropic virus type 1 (HTLV-I) uveitis. Detection of HTLV-I-infected T cells in the eye and their constitutive cytokine production. J Clin Invest 95 (1995) 852-858
2. Yoshida M., Miyoshi I., and Hinuma Y. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci U S A 79 (1982) 2031-2035
3. Poiesz B.J., Ruscetti F.W., Gazdar A.F., Bunn P.A., Minna J.D., and Gallo R.C. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A 77 (1980) 7415-7419
4. Hironaka N., Mochida K., Mori N., Maeda M., Yamamoto N., and Yamaoka S. Tax-independent constitutive IκB kinase activation in adult T-cell leukemia cells. Neoplasia 6 (2004) 266-278
5. Mori N., Fujii M., Ikeda S., et al. Constitutive activation of NF-κB in primary adult T-cell leukemia cells. Blood 93 (1999) 2360-2368
6. Portis T., Harding J.C., and Ratner L. The contribution of NF-κB activity to spontaneous proliferation and resistance to apoptosis in human T-cell leukemia virus type 1 Tax-induced tumors. Blood 98 (2001) 1200-1208
7. Geleziunas R., Ferrell S., Lin X., et al. Human T-cell leukemia virus type 1 Tax induction of NF-κB involves activation of the IκB kinase alpha (IKKα) and IKKβ cellular kinases. Mol Cell Biol 18 (1998) 5157-5165
8. Arima N., Matsushita K., Obata H., et al. NF-κB involvement in the activation of primary adult T-cell leukemia cells and its clinical implications. Exp Hematol 27 (1999) 1168-1175
9. Mori N., Yamada Y., Ikeda S., et al. Bay 11-7082 inhibits transcription factor NF-κB and induces apoptosis of HTLV-I-infected T-cell lines and primary adult T-cell leukemia cells. Blood 100 (2002) 1828-1834
10. Watanabe M., Ohsugi T., Shoda M., et al. Dual targeting of transformed and untransformed HTLV-1-infected T cells by DHMEQ, a potent and selective inhibitor of NF-κB, as a strategy for chemoprevention and therapy of adult T-cell leukemia. Blood 106 (2005) 2462-2471
11. Takeda K., Kaisho T., and Akira S. Toll-like receptors. Annu Rev Immunol 21 (2003) 335-376
12. Dunne A., and O'Neill L.A. The interleukin-1 receptor/Toll-like receptor superfamily: signal transduction during inflammation and host defense. Sci STKE 2003 (2003) re3
13. Muzio M., Polentarutti N., Bosisio D., Manoj Kumar P.P., and Mantovani A. Toll-like receptor family and signalling pathway. Biochem Soc Trans 28 (2000) 563-566
14. Akira S., Yamamoto M., and Takeda K. Role of adapters in Toll-like receptor signalling. Biochem Soc Trans 31 (2003) 637-642
15. Akira S., Takeda K., and Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2 (2001) 675-680
16. O'Neill L.A. The role of MyD88-like adapters in Toll-like receptor signal transduction. Biochem Soc Trans 31 (2003) 643-647
17. Akira S. Toll-like receptor signaling. J Biol Chem 278 (2003) 38105-38108
18. Janssens S., and Beyaert R. A universal role for MyD88 in TLR/IL-1R-mediated signaling. Trends Biochem Sci 27 (2002) 474-482
19. Burns K., Martinon F., Esslinger C., et al. MyD88, an adapter protein involved in interleukin-1 signaling. J Biol Chem 273 (1998) 12203-12209
20. Boch J.A., Yoshida Y., Koyama Y., et al. Characterization of a cascade of protein interactions initiated at the IL-1 receptor. Biochem Biophys Res Commun 303 (2003) 525-531
21. Higashi T., Tsukada J., Yoshida Y., et al. Constitutive tyrosine and serine phosphorylation of STAT4 in T-cells transformed with HTLV-I. Genes Cells 10 (2005) 1153-1162
22. Mori N., and Prager D. Transactivation of the interleukin-1α promoter by human T-cell leukemia virus type I and type II Tax proteins. Blood 87 (1996) 3410-3417
23. Barbulescu K., Becker C., Schlaak J.F., Schmitt E., Meyer zum Buschenfelde K.H., and Neurath M.F. IL-12 and IL-18 differentially regulate the transcriptional activity of the human IFN-γ promoter in primary CD4+ T lymphocytes. J Immunol 160 (1998) 3642-3647
24. Geist L.J., Hopkins H.A., Dai L.Y., He B., Monick M.M., and Hunninghake G.W. Cytomegalovirus modulates transcription factors necessary for the activation of the tumor necrosis factor-α promoter. Am J Respir Cell Mol Biol 16 (1997) 31-37
25. Tsukada J., Misago M., Serino Y., et al. Human T-cell leukemia virus type I Tax transactivates the promoter of human prointerleukin-1β gene through association with two transcription factors, nuclear factor-interleukin-6 and Spi-1. Blood 90 (1997) 3142-3153
26. Tsunekawa B., Wada M., Ikeda M., et al. The binding between the stem regions of human growth hormone (GH) receptor compensates for the weaker site 1 binding of 20-kDa human GH (hGH) than that of 22-kDa hGH. J Biol Chem 275 (2000) 15652-15656
27. Miyairi S., Tateda K., Fuse E.T., et al. Immunization with 3-oxododecanoyl-L-homoserine lactone-protein conjugate protects mice from lethal Pseudomonas aeruginosa lung infection. J Med Microbiol 55 (2006) 1381-1387
28. Schaefer T.M., Desouza K., Fahey J.V., Beagley K.W., and Wira C.R. Toll-like receptor (TLR) expression and TLR-mediated cytokine/chemokine production by human uterine epithelial cells. Immunology 112 (2004) 428-436
29. Mori N., Shirakawa F., Shimizu H., et al. Transcriptional regulation of the human interleukin-6 gene promoter in human T-cell leukemia virus type I-infected T-cell lines: evidence for the involvement of NF-κB. Blood 84 (1994) 2904-2911
30. Adachi O., Kawai T., Takeda K., et al. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 9 (1998) 143-150
31. Gelman A.E., Zhang J., Choi Y., and Turka L.A. Toll-like receptor ligands directly promote activated CD4+ T cell survival. J Immunol 172 (2004) 6065-6073
32. Crellin N.K., Garcia R.V., Hadisfar O., Allan S.E., Steiner T.S., and Levings M.K. Human CD4+ T cells express TLR5 and its ligand flagellin enhances the suppressive capacity and expression of FOXP3 in CD4+CD25+ T regulatory cells. J Immunol 175 (2005) 8051-8059
33. Caron G., Duluc D., Fremaux I., et al. Direct stimulation of human T cells via TLR5 and TLR7/8: flagellin and R-848 up-regulate proliferation and IFN-γ production by memory CD4+ T cells. J Immunol 175 (2005) 1551-1557
34. Caramalho I., Lopes-Carvalho T., Ostler D., Zelenay S., Haury M., and Demengeot J. Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide. J Exp Med 197 (2003) 403-411
35. Jefferies C., Bowie A., Brady G., Cooke E.L., Li X., and O'Neill L.A. Transactivation by the p65 subunit of NF-κB in response to interleukin-1 (IL-1) involves MyD88, IL-1 receptor-associated kinase 1, TRAF-6, and Rac1. Mol Cell Biol 21 (2001) 4544-4552
36. Azimi N., Brown K., Bamford R.N., Tagaya Y., Siebenlist U., and Waldmann T.A. Human T cell lymphotropic virus type I Tax protein trans-activates interleukin 15 gene transcription through an NF-κB site. Proc Natl Acad Sci U S A 95 (1998) 2452-2457
37. Kanno T., Brown K., Franzoso G., and Siebenlist U. Kinetic analysis of human T-cell leukemia virus type I Tax-mediated activation of NF-κB. Mol Cell Biol 14 (1994) 6443-6451
38. Harhaj E.W., and Sun S.C. IKKγ serves as a docking subunit of the IκB kinase (IKK) and mediates interaction of IKK with the human T-cell leukemia virus Tax protein. J Biol Chem 274 (1999) 22911-22914
39. Jin D.Y., Giordano V., Kibler K.V., Nakano H., and Jeang K.T. Role of adapter function in oncoprotein-mediated activation of NF-κB. Human T-cell leukemia virus type I Tax interacts directly with IκB kinase γ. J Biol Chem 274 (1999) 17402-17405
40. Huang G.J., Zhang Z.Q., and Jin D.Y. Stimulation of IKK-γ oligomerization by the human T-cell leukemia virus oncoprotein Tax. FEBS Lett 531 (2002) 494-498
41. Higuchi M., Matsuda T., Mori N., et al. Elevated expression of CD30 in adult T-cell leukemia cell lines: possible role in constitutive NF-κB activation. Retrovirology 2 (2005) 29
42. Claudio E., Brown K., Park S., Wang H., and Siebenlist U. BAFF-induced NEMO-independent processing of NF-κB2 in maturing B cells. Nat Immunol 3 (2002) 958-965
43. Kayagaki N., Yan M., Seshasayee D., et al. BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-κB2. Immunity 17 (2002) 515-524
44. Dejardin E., Droin N.M., Delhase M., et al. The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-κB pathways. Immunity 17 (2002) 525-535
45. Saitoh T., Nakano H., Yamamoto N., and Yamaoka S. Lymphotoxin-β receptor mediates NEMO-independent NF-κB activation. FEBS Lett 532 (2002) 45-51
46. Coope H.J., Atkinson P.G., Huhse B., et al. CD40 regulates the processing of NF-κB2 p100 to p52. EMBO J 21 (2002) 5375-5385
47. Saitoh T., Nakayama M., Nakano H., Yagita H., Yamamoto N., and Yamaoka S. TWEAK induces NF-κB2 p100 processing and long lasting NF-κB activation. J Biol Chem 278 (2003) 36005-36012
48. Kitajima I., Shinohara T., Bilakovics J., Brown D.A., Xu X., and Nerenberg M. Ablation of transplanted HTLV-I Tax-transformed tumors in mice by antisense inhibition of NF-κB. Science 258 (1992) 1792-1795
49. Yamada Y., Ohmoto Y., Hata T., et al. Features of the cytokines secreted by adult T cell leukemia (ATL) cells. Leuk Lymphoma 21 (1996) 443-447
50. Grossman W.J., and Ratner L. Cytokine expression and tumorigenicity of large granular lymphocytic leukemia cells from mice transgenic for the tax gene of human T-cell leukemia virus type I. Blood 90 (1997) 783-794
51. Mori N., Gill P.S., Mougdil T., Murakami S., Eto S., and Prager D. Interleukin-10 gene expression in adult T-cell leukemia. Blood 88 (1996) 1035-1045
52. Franchini G. Molecular mechanisms of human T-cell leukemia/lymphotropic virus type I infection. Blood 86 (1995) 3619-3639
53. Siekevitz M., Feinberg M.B., Holbrook N., Wong-Staal F., and Greene W.C. Activation of interleukin 2 and interleukin 2 receptor (Tac) promoter expression by the trans-activator (tat) gene product of human T-cell leukemia virus, type I. Proc Natl Acad Sci U S A 84 (1987) 5389-5393
54. Mercurio F., Zhu H., Murray B.W., et al. IKK-1 and IKK-2: cytokine-activated IκB kinases essential for NF-κB activation. Science 278 (1997) 860-866
55. Perkins N.D. Achieving transcriptional specificity with NF-κB. Int J Biochem Cell Biol 29 (1997) 1433-1448
56. Faggioli L., Costanzo C., Merola M., et al. Nuclear factor κB (NF-κB), nuclear factor interleukin-6 (NFIL-6 or C/EBPβ) and nuclear factor interleukin-6β (NFIL6-β or C/EBPδ) are not sufficient to activate the endogenous interleukin-6 gene in the human breast carcinoma cell line MCF-7. Comparative analysis with MDA-MB-231 cells, an interleukin-6-expressing human breast carcinoma cell line. Eur J Biochem 239 (1996) 624-631
57. Washizu J., Nishimura H., Nakamura N., Nimura Y., and Yoshikai Y. The NF-κB binding site is essential for transcriptional activation of the IL-15 gene. Immunogenetics 48 (1998) 1-7
58. Schmitz M.L., and Baeuerle P.A. Multi-step activation of NF-κB/Rel transcription factors. Immunobiology 193 (1995) 116-127